The Society For Family Health (SFH) has said that the introduction of self-injection of Depot Medroxyprogesterone acetate (DMPASC), a modern contraceptive method in Nigeria, could increase the uptake of family planning in the country and thereby curb maternal death. This was made known by the Managing Director of the SFH, Omokhudu Idogho at the dissemination of the delivering innovations in self-care (DISC1.0) project, which was held in Lagos recently.
The event was organised by the SFH at the Sheraton Hotels Ikeja, Lagos recently. The SI of Depot Medroxyprogesterone acetate (DMPASC) provides effective contraception with an efficacy of 99 per cent in preventing unintended pregnancy when given correctly. According to Idogho who was represented by Dr.
Jennifer Anyanti, deputy managing director of the SFH, In Nigeria today, the wide range of modern family planning methods, especially the introduction of SI now allows women and their spouse/partner attain the desired number of children they want and determine the spacing of their pregnancies. While affirming the effectiveness of the SI, Idogho said the SFH in partnership with the “Population Services International through the DISC 1.0 project funded by the Children Investment Fund Foundation (CIFFF) has proven for the last four years the hidden power and capacity of the Nigerian primary health care system, the empowered health care provider and most importantly the capability of the average Nigerian woman to take charge of thei.
